Location: Charlotte
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Charlotte
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · Charlotte Gastroenterology and Hepatology, P.L.L.C · Hoffmann-La Roche · NCT06588855A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Levine Cancer Institute · Janssen Research & Development, LLC · NCT06319820Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in
Phase 2 · New Hope Clinical Research - Inpatient unit /ID# 267810 · AbbVie · NCT06846320A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Phase 1 · Levine Children's Hospital ( Site 0022) · Merck Sharp & Dohme LLC · NCT07199465A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase 2 · DJL Clinical Research · Bluefin Biomedicine, Inc. · NCT07105488Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Carolinas Medical Center/Levine Cancer Institute · National Cancer Institute (NCI) · NCT05987241Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Novant Health Cancer Institute - Elizabeth (Breast) · Gilead Sciences · NCT05633654MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Murdock Ambulatory Surgery Center · Stryker Instruments · NCT03072927A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Dermatology, Laser & Vein Specialists of the Carolinas (DLVS · Ipsen · NCT07435428Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia an
Phase 3 · Levine Children's Hospital - Hematology · Vertex Pharmaceuticals Incorporated · NCT05477563A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Phase 3 · Dermatology Specialists of Charlotte · Eli Lilly and Company · NCT05723198Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial SiteCharlotte · TG Therapeutics, Inc. · NCT05877963A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT05123482Pre-malignant States to Hematologic Malignancies in Firefighters
Phase N/A · Levine Cancer Institute · Wake Forest University Health Sciences · NCT06870760A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 3 · Levine Cancer Institute · Janssen Research & Development, LLC · NCT07164443A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Novant Health Cancer Institute ( Site 0019) · Merck Sharp & Dohme LLC · NCT07060807A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell C
Phase 3 · Research Site · AstraZeneca · NCT06129864AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT05850234Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · Carolinas Medical Center/Levine Cancer Institute · National Cancer Institute (NCI) · NCT07061977A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Phase 1/Phase 2 · Levine Cancer Center · Nimbus Wadjet, Inc. · NCT06898450A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metasta
Phase 2 · Ohio State University-Telemedicine · Sameek Roychowdhury · NCT06906562Long-Term Stability of the Glide Control Strategy
NA · Medical Center Orthotics and Prosthetics - Charlotte · Infinite Biomedical Technologies · NCT07222085Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Carolinas Medical Center/Levine Cancer Institute · SWOG Cancer Research Network · NCT04205968Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Phase 4 · Atrium Health · Duke University · NCT04262206A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipola
Phase 3 · DelRicht Research · Xenon Pharmaceuticals Inc. · NCT07172516Follow-up Visit of High Risk Infants
Phase N/A · Wake Forest University · NICHD Neonatal Research Network · NCT00009633A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light
Phase 1 · Levine Cancer Institute · Janssen Research & Development, LLC · NCT05652335A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderate
Phase 3 · Charlotte Gastroenterology and Hepatology, P.L.L.C · Hoffmann-La Roche · NCT06819891A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil
Phase 3 · Levine Cancer Institute · Incyte Corporation · NCT06615050Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
Phase 3 · Queen City Clinical Research, PLLC · Saol Therapeutics Inc · NCT07226258
Look up another city
Look up another condition